Feedback / Questions
Hetronifly (serplulimab) - Fosun Pharma
https://www.prnewswire.com/news-releases/phase-3-clinical-trial-of-hansizhuang-plus-chemotherapy-meets-primary-endpoint-in-neoadjuvantadjuvant-gastric-cancer-greenlighting-early-nda-submission-302579700.html
Oct 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next